Revisiting the Term Neuroprotection in Chronic and Degenerative Diseases

Thanks to the development of several new researches, the lifetime presented a significant increase, even so, we still have many obstacles to overcome - among them, manage and get responses regarding neurodegenerative diseases. Where we are in the understanding of neuroprotection? Do we really have p...

Full description

Saved in:
Bibliographic Details
Published inNeurology international Vol. 8; no. 1; p. 6311
Main Authors Orsini, Marco, Nascimento, Osvaldo J M, Matta, Andre P C, Reis, Carlos Henrique Melo, de Souza, Olivia Gameiro, Bastos, Victor Hugo, Moreira, Rayele, Ribeiro, Pedro, Fiorelli, Stenio, Novellino, Pietro, Pessoa, Bruno, Cunha, Mariana, Pupe, Camila, Morales, Pedro S, Filho, Pedro F Moreira, Trajano, Eduardo Lima, Oliveira, Acary Bulle
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 01.04.2016
PAGEPress Publications
PAGEPress Publications, Pavia, Italy
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Thanks to the development of several new researches, the lifetime presented a significant increase, even so, we still have many obstacles to overcome - among them, manage and get responses regarding neurodegenerative diseases. Where we are in the understanding of neuroprotection? Do we really have protective therapies for diseases considered degeneratives such as amyotrophic lateral sclerosis and its variants, Parkinson's disease, Alzheimer's disease and many others? Neuroprotection is defined by many researches as interactions and interventions that can slow down or even inhibit the progression of neuronal degeneration process. We make some considerations on this neuroprotective effect.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Contributions: the authors contributed equally.
Conflict of interest: the authors declare no potential conflict of interest.
ISSN:2035-8385
2035-8377
DOI:10.4081/ni.2016.6311